Pila Pharma AB (publ) (PILA.ST)

SEK 3.87

(5.16%)

Total Debt Summary of Pila Pharma AB (publ)

  • Pila Pharma AB (publ)'s latest annual total debt in 2023 was 773.08 Thousand SEK , down 0.0% from previous year.
  • Pila Pharma AB (publ)'s latest quarterly total debt in 2024 Q2 was - SEK , down 0.0% from previous quarter.
  • Pila Pharma AB (publ) reported annual total debt of - SEK in 2022, down 0.0% from previous year.
  • Pila Pharma AB (publ) reported annual total debt of - SEK in 2021, down -100.0% from previous year.
  • Pila Pharma AB (publ) reported quarterly total debt of - SEK for 2024 Q2, down 0.0% from previous quarter.
  • Pila Pharma AB (publ) reported quarterly total debt of 773.08 Thousand SEK for 2023 Q4, down -48.46% from previous quarter.

Annual Total Debt Chart of Pila Pharma AB (publ) (2023 - 2015)

Historical Annual Total Debt of Pila Pharma AB (publ) (2023 - 2015)

Year Total Debt Total Debt Growth
2023 773.08 Thousand SEK 0.0%
2022 - SEK 0.0%
2021 - SEK -100.0%
2020 500 Thousand SEK 0.0%
2019 - SEK 0.0%
2018 - SEK -100.0%
2017 80 Thousand SEK -81.82%
2016 440 Thousand SEK 780.0%
2015 50 Thousand SEK 0.0%

Peer Total Debt Comparison of Pila Pharma AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 95.197%
Ziccum AB (publ) 857 Thousand SEK 9.792%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 84.473%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 96.843%
Genovis AB (publ.) 79.32 Million SEK 99.025%
Intervacc AB (publ) 181 Thousand SEK -327.116%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 96.249%
Active Biotech AB (publ) 3 Million SEK 74.231%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 98.718%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 84.538%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 98.917%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 90.124%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -82.33%
Egetis Therapeutics AB (publ) 108.6 Million SEK 99.288%
Karolinska Development AB (publ) 3.07 Million SEK 74.818%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK 70.036%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 22.692%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.921%
Camurus AB (publ) 24.5 Million SEK 96.845%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 97.196%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.911%
Cyxone AB (publ) 858 Thousand SEK 9.897%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK 54.817%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 97.9%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -16.078%
SynAct Pharma AB 637 Thousand SEK -21.363%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK 9.049%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 56.1%
BioInvent International AB (publ) 23.24 Million SEK 96.674%
Alzinova AB (publ) 800 Thousand SEK 3.365%
Oncopeptides AB (publ) 106.48 Million SEK 99.274%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.148%
Diamyd Medical AB (publ) 30.67 Million SEK 97.48%
Xbrane Biopharma AB (publ) 231.47 Million SEK 99.666%
Ascelia Pharma AB (publ) 1.06 Million SEK 27.137%
Diagonal Bio AB (publ) - SEK -Infinity%